SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Click Holdings Ltd. operates as a holding company which provides temporary and permanent personnel solutions. Its services include professional solution services, nursing solution services, and logistics and other solution services. The company was founded by Chan Chun Sing on January 31, 2024 and is headquartered in Hong Kong.

Click Holdings Ltd. - Ordinary Shares - Class A

Click Holdings Limited

CLIK is trending due to a reported surge in revenue and a small float, sparking excitement about a potential massive run. The community is focused on the stock's low float and are watching for news catalysts, drawing comparisons to other stocks with similar setups. Some traders are also pointing to the stock's chart patterns as a reason for optimism.

Newegg Commerce, Inc. is an e-commerce company. It offers direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products. The firm also provides third-party logistics services globally. The company was founded on July 22, 2003 and is headquartered in City of Industry, CA.

Newegg Commerce Inc

NEGG is trending as traders discuss a potential short squeeze, noting high borrowing costs and a seemingly limited float. Community members are debating the impact of insider activity and monitoring short interest data. Some investors suggest a buy-and-hold strategy, while others point to technical indicators.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is trending due to discussions surrounding Amazon's competitive moves in the DSP space, sparking debates about market share and potential impacts. The community is analyzing Amazon's recent offer of head-to-head testing and ADWEEK's reporting of it. Investors are closely watching Trade Desk's response and its long-term strategies in a competitive landscape.

ETHZilla Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J. Steinman, and Jonathan B. Rothbard on September 7, 2016 and is headquartered in Palm Beach, FL.

ETHZilla Corp

ETHZilla Corporation

ETHZ is trending as investors discuss its potential undervaluation relative to its Ethereum holdings, amplified by interest from meme stock communities and the disclosed stake of an activist investor. Community talking points revolve around its asset value, potential for a short squeeze given the low float, and comparison to other Ethereum treasury plays. However, concerns persist regarding potential dilution from convertible notes and the company's cash burn.

Picard Medical, Inc. is a medical technology company, which manufactures and sells the only U.S. FDA, and Health Canada approved implantable SynCardia TAH. It develops the first fully implantable SynCardia TAH as an alternative to heart transplantation for patients with biventricular heart failure in the U.S. and around the world. The company is headquartered in Tucson, AZ.

Picard Medical Inc.

Picard Medical (PMI) is trending amid significant stock volatility, prompting the company to release a statement clarifying they are unaware of any undisclosed material changes. The community is actively discussing potential dilution, short covering, and speculating about a possible pump and dump, while some remain bullish, citing the company's unique position in the artificial heart market.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals is trending due to an upcoming FDA decision on their drug Revuforj for a specific type of leukemia, with the community actively discussing the potential market impact and likelihood of approval. While some express concerns about potential side effects and a history of sell-offs post-approval, others point to the drug's efficacy and the company's strong financial position, anticipating a significant upside if approved. Community members are closely monitoring discussions around analyst price targets, short interest, and potential buyout scenarios.

Meet DragonWifBeard: The world's first AI-powered pet dragon!  More Than Just Scales: DragonWifBeard is a real-life bearded dragon revolutionizing the pet experience. He's not just any reptile – he's equipped with cutting-edge Eliza AI agent, giving him a unique personality and the ability to interact with his environment in unprecedented ways. The Future of Companionship: This groundbreaking project merges the love for pets with the limitless possibilities of AI. Witness the dawn of a new era in companionship with DragonWithBeard.

DragonWifBeard

DragonWifBeard ($DWB) is trending as the community emphasizes its potential for profit, particularly its availability on Phantom Wallet. The conversation highlights a blend of 'ancient' and 'modern' gains, with users frequently mentioning fire and wisdom as key themes. The coin's association with other Solana tokens is also part of the discussion.

Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. Its lead product candidate, Temferon, was developed using its platform and carries an interferon-alpha payload. The company was founded by Pierluigi Paracchi, Luigi Naldini and Bernhard Gentner on July 24, 2014 and is headquartered in Milan, Italy.

Genenta Science SpA - ADR

GNTA is experiencing significant volatility, with community members actively discussing a large pre-market surge following news of a strategic partnership. The conversation includes speculation about a short squeeze, potential for further gains, and caution due to the stock's history of volatile price action and possible pump and dump schemes. Some traders are taking profits while others are holding in anticipation of after-hours movement.

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Teva- Pharmaceutical Industries Ltd. - ADR

Teva is trending as community members discuss its potential and setbacks, with some pointing to a recent FDA approval for Uzedy as a positive catalyst. Despite some positive news, negative sentiment persists regarding the stock's performance and leadership. Analysts are weighing in, with price target adjustments and discussions around the company's "Pivot to Growth" strategy.

ADMA Biologics, Inc. operates as a biopharmaceutical company, which is engaged in manufacturing, marketing, and developing specialty plasma-derived biologics. The firm operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate. The ADMA BioManufacturing segment consists of immune globulin manufacturing and development operations. The Plasma Collection Center consists of source plasma collection facilities. The Corporate segment includes general and administrative overhead expenses. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 24, 2004 and is headquartered in Ramsey, NJ.

Adma Biologics Inc

ADMA Biologics is trending amid community discussion around a recent FDA investigation into allergic reactions linked to specific lots of intravenous immune globulin (IVIG) drugs, including two ADMA products; although these reactions are acknowledged as rare, the news has sparked concerns and trading volatility. Some investors view the dip as a buying opportunity, citing the company's strong fundamentals and potential for a pre-earnings run, while others express frustration with the stock's recent performance and management's silence.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

WDC Surges 129% in 6 Months: How Should Investors Play the Stock?

Western Digital's shares have soared 128.8% in six months as AI demand, high-capacity drives and debt reduction fuel momentum near 52-week highs.

Futures Flat Ahead Of Retail Sales, Trump-Putin Summit

Futures Flat Ahead Of Retail Sales, Trump-Putin Summit US equity futures are slightly higher , hovering near all time highs as traders bet that data on Friday will bolster the case for interest rate...

Mizuho lifts targets on storage and memory stocks on strong AI demand

Investing.com -- Mizuho raised its price targets on key storage and memory stocks, Seagate,  Western Digital  (NASDAQ:WDC), and SanDisk, in a note Thursday, citing accelerating demand driven by AI infrastructure. 

Goldman Sachs bullish on LRCX, AMAT, and STX  in new semiconductor call

Investing.com -- Goldman Sachs initiated coverage on U.S. semiconductor capital equipment, storage, and foundry stocks in a note Thursday, holding a “balanced view,” highlighting mid-cycle dynamics that present selective opportunities. 

Flash storage solutions provider Sandisk Corp. (SNDK), which&nbsp;spun off publicly from Western Digital (WDC) in February, received a bullish&nbsp;call from a Wall Street firm.<a href="https://stocktwits.com/symbol/SNDK">Sandisk stock</a> has gained about 29% since its spin-off in February.Jefferies analyst Blayne Curtis initiated coverage of Sandisk stock with a ‘Buy’ rating and a $60 price target,&nbsp;The Fly reported. The stock price target implies roughly a 30% upside from Thursday’s close.Curtis believes the spin-off could unlock shareholder value as updated technology drives enterprise solid state drives market share gains.&nbsp;The analyst sees&nbsp;an upside to estimates If SanDisk's content trends sustain amid tariffs.Last week, Benchmark added Sandisk stock to its “Best Ideas” list and raised the price target to $62 from $58. The firm maintained a ‘Buy’ rating on the stock. The research firm based its optimism on its view that the NAND business was entering a cyclical upturn, driven by artificial intelligence (AI) opportunities and double-digit&nbsp;growth in data center spending.The&nbsp;research firm believes that SanDisk's next-generation products, namely BiCS8 chips and ultra QLC technology, will drive share gains in the enterprise solid-state drive (SSD) market.In early June, the company announced a secondary offering of its shares held by its erstwhile parent, Western Digital, with the offering&nbsp;comprising 18.54 million shares priced at $38.50&nbsp;each.&nbsp;On Stocktwits, retail sentiment toward Sandisk stock was ‘bearish’ by early Monday, worsening from the ‘neutral’ mood a day ago. The message volume was ‘low.’<figure class="image"><img style="aspect-ratio:622/53;" src="https://news.stocktwits-cdn.com/Screenshot_2025_07_07_at_4_36_41_AM_png_5282c1af92.webp" alt="Screenshot 2025-07-07 at 4.36.41 AM.png" width="622" height="53"><figcaption>SNDK sentiment and message volume as of 4:37 a.m. ET, July 7 | source: Stocktwits</figcaption></figure>Sandisk ended Thursday’s session up 0.43% at $46.41.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/oracle-reportedly-offers-us-government-steep-discounts/chFtfACR5TN">Oracle Reportedly Offers US Government Steep Discounts: Retail Traders Raise Eyebrows As Stock Scales New Peaks</a>

In this photo illustration, the SanDisk Corporation logo is displayed on a smartphone screen. 

Sandisk Gets Bullish Initiation From Jefferies, But Retail Sentiment Lags

Analyst Blayne Curtis believes the spin-off could unlock shareholder value as updated technology drives the enterprise solid-state drive maker’s market share gains. 

Equity

Analyst Blayne Curtis believes the spin-off could unlock shareholder value as updated technology drives the enterprise solid-state drive maker’s market share gains. 


Citi starts Sandisk at Buy on NAND recovery and enterprise SSD push; stock rises

Investing.com -- Citi Research has begun coverage of SanDisk Corporation (NASDAQ:SNDK) with a Buy rating and a $57 price target, which implies roughly 21% upside from the stock’s Wednesday closing price.

BofA starts Sandisk at Buy on margin upside, NAND recovery prospects

Investing.com -- Sandisk Corp was initiated with a Buy rating and a price objective of $61 by BofA, which sees the flash storage maker as a key beneficiary of an early-stage recovery in NAND pricing and improving operating margins.

This 1 Unlikely Small-Cap Is an S&P Standout in 2025, But Is It a Buy Right Now?

With Western Digital’s spinoff complete, SanDisk makes its mark in the S&P SmallCap 600. So, is this a wise time to pay attention?

Flash and advanced memory technology company Sandisk Corp. (SNDK) began trading as an independent public&nbsp;entity on Feb. 24, following its separation from Western Digital Corp. (WDC).This marked a relisting of the stock as Sandisk was a public-traded company before it was acquired by Western Digital in 2016.Since its relisting, Sandisk's stock has risen about 40%, even amid the broader market volatility.&nbsp;On Tuesday, Morgan Stanley analyst Joseph Moore initiated coverage of SanDisk stock with an ‘Overweight’ rating and a $84 price target, suggesting a 67% upside potential.The analyst noted that in 2024, Sandisk had a 14% share of the global market for NAND, a non-volatile storage technology that does not require power to retain data. Considering its partnership with its development/manufacturing joint venture partner Kioxia, Sandisk's global market share increases to 30%.Moore noted that the NAND cycle recovered from the 2024 lows, and the improvement increased utilization, resulting in a modestly oversupplied situation.Morgan Stanley expects the NAND market to be tough in the first half of 2025. Nevertheless, it is expected to have a 90% upside in twelve months as cyclical drivers reverse for an underappreciated franchise, it added.Moore said, “Despite uncertainty, this is one of the best risk/rewards in our coverage.”Stocktwits users are largely bullish on&nbsp;<a href="https://stocktwits.com/symbol/SNDK">Sandisk stock</a>.&nbsp;One user said the stock is grossly undervalued and has huge upside potential.<stembedurl>https://stocktwits.com/milieupower/message/606049893</stembedurl>Another user was bullish about the company’s technology. According to them, a new high bandwidth flash (HBF) patent could have applications for every computer.<stembedurl>https://stocktwits.com/milieupower/message/606049893</stembedurl>At last check, Sandisk stock was down 2.98% at $48.65 amid the broader market weakness.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next: <a href="https://stocktwits.com/news-articles/markets/equity/super-micro-stock-bucks-trump-tariff-induced-broader-market-weakness/chejs6URCF">Super Micro Stock Bucks Trump Tariff-Induced Broader Market Weakness: Retail Persists With Bullish Stance</a>

SanDisk adapter and microSD card are seen in this illustration photo taken in Krakow, Poland on January 30, 2023.

Sandisk Analyst Predicts Nearly 70% Upside For Relisted Stock: Retail’s Excited

Since its Feb. 24 listing, Sandisk stock has risen about 40%, even amid the broader market volatility. 

Sandisk Celebrates Nasdaq Listing After Completing Separation from Western Digital

Sandisk Corporation, a global Flash and advanced memory technology innovator, today announced that the company has completed its separation from Western Digital and is now an independent public...

SanDisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Cut 25 bps

Cut 50+ bps

No change

What will the Fed decide at its October meeting? Polymarket gives a 92% chance of a 25 bps cut. 
 
*Powered by Polymarket

SNDK
Sandisk Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SNDK News

SNDKSandisk Corp